Search

Stacey Nee Macfarlane

Examiner (ID: 8364, Phone: (571)270-3057 , Office: P/1649 )

Most Active Art Unit
1649
Art Unit(s)
1609, 1649, 1675
Total Applications
1032
Issued Applications
433
Pending Applications
132
Abandoned Applications
495

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17586556 [patent_doc_number] => 11324798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-10 [patent_title] => Materials and methods for treatment of inflammation [patent_app_type] => utility [patent_app_number] => 16/986802 [patent_app_country] => US [patent_app_date] => 2020-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 10701 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16986802 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/986802
Materials and methods for treatment of inflammation Aug 5, 2020 Issued
Array ( [id] => 16613666 [patent_doc_number] => 20210032319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => TAU IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 16/933792 [patent_app_country] => US [patent_app_date] => 2020-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21750 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16933792 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/933792
Tau immunotherapy Jul 19, 2020 Issued
Array ( [id] => 17865340 [patent_doc_number] => 20220288075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => METHOD AND COMPOSITION FOR TREATING PAIN [patent_app_type] => utility [patent_app_number] => 17/625434 [patent_app_country] => US [patent_app_date] => 2020-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18609 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625434 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/625434
METHOD AND COMPOSITION FOR TREATING PAIN Jul 9, 2020 Pending
Array ( [id] => 16391021 [patent_doc_number] => 20200331962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-22 [patent_title] => NOVEL THERAPEUTIC USES OF MU-OPIATE RECEPTOR PEPTIDES [patent_app_type] => utility [patent_app_number] => 16/921223 [patent_app_country] => US [patent_app_date] => 2020-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6579 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16921223 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/921223
NOVEL THERAPEUTIC USES OF MU-OPIATE RECEPTOR PEPTIDES Jul 5, 2020 Abandoned
Array ( [id] => 17952481 [patent_doc_number] => 11478556 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-25 [patent_title] => Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine [patent_app_type] => utility [patent_app_number] => 16/909896 [patent_app_country] => US [patent_app_date] => 2020-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 44 [patent_no_of_words] => 20092 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909896 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/909896
Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine Jun 22, 2020 Issued
Array ( [id] => 16345145 [patent_doc_number] => 20200309795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => DIAGNOSTIC BIOMARKER PROFILES FOR THE DETECTION AND DIAGNOSIS OF ALZHEIMER'S DISEASE [patent_app_type] => utility [patent_app_number] => 16/902829 [patent_app_country] => US [patent_app_date] => 2020-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28838 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902829 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/902829
DIAGNOSTIC BIOMARKER PROFILES FOR THE DETECTION AND DIAGNOSIS OF ALZHEIMER'S DISEASE Jun 15, 2020 Abandoned
Array ( [id] => 17928281 [patent_doc_number] => 20220323406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => METHODS AND COMPOSITIONS FOR DIFFERENTIATING STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/617048 [patent_app_country] => US [patent_app_date] => 2020-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84498 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617048 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/617048
METHODS AND COMPOSITIONS FOR DIFFERENTIATING STEM CELLS Jun 4, 2020 Pending
Array ( [id] => 17881230 [patent_doc_number] => 20220296707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => ANTI-OPIOID COMPOUNDS AND METHODS OF MAKING AND USING SAME [patent_app_type] => utility [patent_app_number] => 17/616031 [patent_app_country] => US [patent_app_date] => 2020-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27919 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616031 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/616031
ANTI-OPIOID COMPOUNDS AND METHODS OF MAKING AND USING SAME Jun 3, 2020 Pending
Array ( [id] => 16420579 [patent_doc_number] => 20200345777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-05 [patent_title] => NOVEL IMMUNOTHERAPY AGAINST NEURONAL AND BRAIN TUMORS [patent_app_type] => utility [patent_app_number] => 16/891841 [patent_app_country] => US [patent_app_date] => 2020-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24084 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16891841 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/891841
Immunotherapy against neuronal and brain tumors Jun 2, 2020 Issued
Array ( [id] => 19197290 [patent_doc_number] => 11994522 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-28 [patent_title] => Biomarker detection process and assay of neurological condition [patent_app_type] => utility [patent_app_number] => 16/890943 [patent_app_country] => US [patent_app_date] => 2020-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 11416 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890943 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/890943
Biomarker detection process and assay of neurological condition Jun 1, 2020 Issued
Array ( [id] => 16345139 [patent_doc_number] => 20200309789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS [patent_app_type] => utility [patent_app_number] => 16/890739 [patent_app_country] => US [patent_app_date] => 2020-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11479 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890739 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/890739
BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS Jun 1, 2020 Abandoned
Array ( [id] => 17490622 [patent_doc_number] => 11279914 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-22 [patent_title] => Assembly of functionally integrated human forebrain spheroids and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/884980 [patent_app_country] => US [patent_app_date] => 2020-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 143 [patent_no_of_words] => 26415 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 339 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16884980 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/884980
Assembly of functionally integrated human forebrain spheroids and methods of use thereof May 26, 2020 Issued
Array ( [id] => 16512966 [patent_doc_number] => 20200392224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-17 [patent_title] => METHODS FOR TREATING SYSTEMIC SCLEROSIS [patent_app_type] => utility [patent_app_number] => 16/881863 [patent_app_country] => US [patent_app_date] => 2020-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30558 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16881863 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/881863
Methods for treating systemic sclerosis May 21, 2020 Issued
Array ( [id] => 16557576 [patent_doc_number] => 20210002724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => Genome-Based Methods For Reducing Cardiovascular Risk [patent_app_type] => utility [patent_app_number] => 16/876030 [patent_app_country] => US [patent_app_date] => 2020-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19079 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16876030 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/876030
Genome-based methods for reducing cardiovascular risk May 15, 2020 Issued
Array ( [id] => 17664164 [patent_doc_number] => 11357840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-14 [patent_title] => Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors [patent_app_type] => utility [patent_app_number] => 15/931081 [patent_app_country] => US [patent_app_date] => 2020-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 24246 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931081 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/931081
Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors May 12, 2020 Issued
16/872064 DETECTION OF DEBRIS IN RECIRCULATING PHAGOCYTES May 10, 2020 Abandoned
Array ( [id] => 16570659 [patent_doc_number] => 20210009665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => ANTIBODIES TO AMYLOID BETA [patent_app_type] => utility [patent_app_number] => 16/864439 [patent_app_country] => US [patent_app_date] => 2020-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49464 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864439 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/864439
Antibodies to amyloid beta Apr 30, 2020 Issued
Array ( [id] => 17434800 [patent_doc_number] => 11260106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-01 [patent_title] => Compositions and methods for treatment of GCASE related disease states [patent_app_type] => utility [patent_app_number] => 16/860319 [patent_app_country] => US [patent_app_date] => 2020-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 53 [patent_no_of_words] => 7920 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860319 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/860319
Compositions and methods for treatment of GCASE related disease states Apr 27, 2020 Issued
Array ( [id] => 17658467 [patent_doc_number] => 20220178932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => CANCER DETECTION METHOD AND DETECTION REAGENT [patent_app_type] => utility [patent_app_number] => 17/605327 [patent_app_country] => US [patent_app_date] => 2020-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13147 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605327 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/605327
CANCER DETECTION METHOD AND DETECTION REAGENT Apr 14, 2020 Abandoned
Array ( [id] => 16361364 [patent_doc_number] => 20200318115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => GENE THERAPIES FOR LYSOSOMAL DISORDERS [patent_app_type] => utility [patent_app_number] => 16/838993 [patent_app_country] => US [patent_app_date] => 2020-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10995 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16838993 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/838993
Gene therapy for neurodegenerative disorders Apr 1, 2020 Issued
Menu